Bottom line
How much do SWHFX and HRTS overlap?
57% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 57.0% of SWHFX's assets and 51.9% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings SWHFX and HRTS have in common
| Holding | % of SWHFX | % of HRTS | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.92% | 11.52% | 11.52% |
| Johnson & Johnson | 6.94% | 3.59% | 3.59% |
| AbbVie Inc | 5.81% | 2.40% | 2.40% |
| Merck & Co Inc | 4.98% | 4.27% | 4.27% |
| UnitedHealth Group Inc | 4.74% | 5.24% | 4.74% |
| Gilead Sciences Inc | 3.24% | 3.43% | 3.24% |
| Novartis AG | 2.92% | 3.38% | 2.92% |
| Amgen Inc | 2.58% | 1.91% | 1.91% |
| Bristol-Myers Squibb Co | 2.44% | 2.09% | 2.09% |
| Medtronic PLC | 2.29% | 1.88% | 1.88% |
| Thermo Fisher Scientific Inc | 2.16% | 3.97% | 2.16% |
| Vertex Pharmaceuticals Inc | 1.89% | 2.93% | 1.89% |
| Abbott Laboratories | 1.60% | 2.61% | 1.60% |
| Danaher Corp | 1.47% | 2.66% | 1.47% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in SWHFX
- Roche Holding AG — 2.29%
- Stryker Corp — 2.11%
- Gsk Plc — 1.73%
- Boston Scientific Corp — 1.60%
- Cigna Group/The — 1.51%
- Elevance Health Inc — 1.45%
- Incyte Corp — 1.37%
- Ipsen SA — 1.34%
- Sanofi SA — 1.31%
- Becton Dickinson & Co — 1.24%
- Astellas Pharma Inc — 1.19%
Only in HRTS
- Novo Nordisk A/S — 5.24%
- Roche Holding AG — 4.50%
- AstraZeneca PLC — 4.00%
- Revolution Medicines Inc — 3.33%
- Bridgebio Pharma Inc — 2.59%
- Cytokinetics Inc — 2.52%
- Teva Pharmaceutical Industries — 2.06%
- Dexcom Inc — 1.92%
- Edwards Lifesciences Corp — 1.75%
- McKesson Corp — 1.71%
- Regeneron Pharmaceuticals Inc — 1.67%
Asset mix
| Asset type | SWHFX | HRTS |
|---|---|---|
| Stocks | 99.0% | 99.2% |
| Cash & short-term funds | — | 0.7% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Country mix
| Country | SWHFX | HRTS |
|---|---|---|
| US | 78.6% | 74.9% |
| CH | 5.2% | 7.9% |
| DK | 0.7% | 7.0% |
| IE | 4.5% | 1.9% |
| GB | 3.4% | 4.0% |
| FR | 2.6% | — |
| JP | 2.3% | 1.3% |
| IL | — | 2.1% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do SWHFX and HRTS overlap?
What stocks do SWHFX and HRTS have in common?
Should I own both SWHFX and HRTS?
Which holds more stocks, SWHFX or HRTS?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.